PRESCRIBING INFORMATION
INDICATIONS Fluimucil® A is indicated as an adjuvant treatment in certain clinical conditions characterized by the presence of thick and viscous mucoid or mucopurulent secretions such as: chronic bronchopulmonary diseases (chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis, bronchiectasis) and acute bronchopulmonary disease (asthma with bronchial mucus plugging, bronchitis, bronchopneumonia, tracheobronchitis, branchiolitis, pulmonary complications of cystic fibrosis, pulmonary complications associated with sugery).
DOSAGE AND ADMINISTRATION For Adults (6 years old or above): 2 sachets Fluimucil® A 100, 3 times a day; or 1 effervescent tablet of Fluimucil® A 600 a day (preferably in the evening). During exacerbation, 2 effervescent tablets are recommended.
For children, 1 sachet of Fluimucil® A 100 from 2 to 4 times a day, according to age. The duration of treatment should be 5 to 10 days in acute treatment, whereas it may be continued in chronic states for several months, according to the advice of the physicians.
PREPARATION Dissolve the effervescent tablet or the contents of each sachet in a glass containing a small quantity of water, mixing it, if necessary, with a spoon. A palatable solution is thus obtained, which can be drunk directly from the glass or, in the case of infants, be given a teaspoon or in a feeding bottle.
Indications and dosages may vary from country to country. Please refer to local product insert for more information.